These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumoniae infection and tumor necrosis factor-alpha. Uriarte SM; Molestina RE; Miller RD; Bernabo J; Farinati A; Eiguchi K; Ramirez JA; Summersgill JT J Infect Dis; 2002 Jun; 185(11):1631-6. PubMed ID: 12023769 [TBL] [Abstract][Full Text] [Related]
28. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. MacIntyre A; Abramov R; Hammond CJ; Hudson AP; Arking EJ; Little CS; Appelt DM; Balin BJ J Neurosci Res; 2003 Mar; 71(5):740-50. PubMed ID: 12584732 [TBL] [Abstract][Full Text] [Related]
29. The role of Chlamydia pneumoniae in cardiovascular disease. Gaydos CA; Quinn TC Adv Intern Med; 2000; 45():139-73. PubMed ID: 10635048 [No Abstract] [Full Text] [Related]
30. Chlamydia pneumoniae stimulates the proliferation of HUVEC through the induction of VEGF by THP-1. Carratelli CR; Paolillo R; Rizzo A Int Immunopharmacol; 2007 Mar; 7(3):287-94. PubMed ID: 17276886 [TBL] [Abstract][Full Text] [Related]
31. [Chlamydia pneumoniae as a causative agent in atherosclerosis]. van Deventer SJ Ned Tijdschr Geneeskd; 1999 Feb; 143(6):288-90. PubMed ID: 10221082 [TBL] [Abstract][Full Text] [Related]
32. Iron enhances endothelial cell activation in response to Cytomegalovirus or Chlamydia pneumoniae infection. Kartikasari AE; Georgiou NA; de Geest M; van Kats-Renaud JH; Bouwman JJ; van Asbeck BS; Marx JJ; Visseren FL Eur J Clin Invest; 2006 Oct; 36(10):743-52. PubMed ID: 16968471 [TBL] [Abstract][Full Text] [Related]
33. Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Molestina RE; Dean D; Miller RD; Ramirez JA; Summersgill JT Infect Immun; 1998 Apr; 66(4):1370-6. PubMed ID: 9529055 [TBL] [Abstract][Full Text] [Related]
34. Role of infections in atherogenesis. Laroia ST; Ganti AK; Potti A Indian Heart J; 2003; 55(1):27-34. PubMed ID: 12760584 [No Abstract] [Full Text] [Related]
36. [Chlamydia pneumoniae infection and atherosclerosis]. Sumarokov AB; Liakishev AA Klin Med (Mosk); 1999; 77(7):4-10. PubMed ID: 10483155 [No Abstract] [Full Text] [Related]
37. Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae. Maass M; Gieffers J; Solbach W Herz; 2000 Mar; 25(2):68-72. PubMed ID: 10829241 [TBL] [Abstract][Full Text] [Related]
38. [The role of Chlamydia pneumoniae infection in the development of atherosclerosis in humans]. Kotyla PJ; Sliwińska-Kotyla B; Kucharz EJ Pol Arch Med Wewn; 2002 Dec; 108(6):1239-44. PubMed ID: 12687938 [No Abstract] [Full Text] [Related]
39. [Chlamydia pneumoniae as a biological factor contributing to pathological changes of arterial walls in patients with atherosclerosis]. Walski M; Chomicz L; Dabrowska J; Zebrowska J; Dudziński T Przegl Epidemiol; 2003; 57(2):255-62. PubMed ID: 12910592 [TBL] [Abstract][Full Text] [Related]
40. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. Quinn TC; Gaydos CA Am Heart J; 1999 Nov; 138(5 Pt 2):S507-11. PubMed ID: 10539860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]